Hang Dong

591 total citations
21 papers, 445 citations indexed

About

Hang Dong is a scholar working on Epidemiology, Oncology and Biomedical Engineering. According to data from OpenAlex, Hang Dong has authored 21 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 5 papers in Oncology and 5 papers in Biomedical Engineering. Recurrent topics in Hang Dong's work include Nanoplatforms for cancer theranostics (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and Immune Cell Function and Interaction (2 papers). Hang Dong is often cited by papers focused on Nanoplatforms for cancer theranostics (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and Immune Cell Function and Interaction (2 papers). Hang Dong collaborates with scholars based in China, Hong Kong and Japan. Hang Dong's co-authors include Rong Gui, Xueyuan Huang, Kam‐Ming Ko, Zhi‐Ling Yu, Haiting Liu, Yinghui Shang, Qiangqiang Zhao, Wansong Chen, Si-Yuan Pan and Bin Wu and has published in prestigious journals such as ACS Applied Materials & Interfaces, Journal of Hepatology and European Journal of Pharmacology.

In The Last Decade

Hang Dong

20 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hang Dong China 12 150 119 89 73 73 21 445
Zhen Liang China 16 239 1.6× 97 0.8× 59 0.7× 83 1.1× 67 0.9× 41 681
Xiaojun Ji China 12 192 1.3× 86 0.7× 58 0.7× 38 0.5× 52 0.7× 27 533
Melissa Skibba United States 13 242 1.6× 59 0.5× 58 0.7× 74 1.0× 46 0.6× 21 547
Shengju Yang China 11 224 1.5× 32 0.3× 104 1.2× 47 0.6× 39 0.5× 18 534
Jia Gu China 15 307 2.0× 118 1.0× 65 0.7× 29 0.4× 88 1.2× 28 747
Jiaxuan Qiu China 15 483 3.2× 63 0.5× 143 1.6× 65 0.9× 50 0.7× 31 966
Yue Pan China 14 314 2.1× 91 0.8× 184 2.1× 72 1.0× 41 0.6× 34 866
Ruiyan Pan China 17 249 1.7× 65 0.5× 49 0.6× 72 1.0× 74 1.0× 42 577
Maolei Xu China 14 375 2.5× 72 0.6× 40 0.4× 52 0.7× 30 0.4× 36 701

Countries citing papers authored by Hang Dong

Since Specialization
Citations

This map shows the geographic impact of Hang Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hang Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hang Dong more than expected).

Fields of papers citing papers by Hang Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hang Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hang Dong. The network helps show where Hang Dong may publish in the future.

Co-authorship network of co-authors of Hang Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Hang Dong. A scholar is included among the top collaborators of Hang Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hang Dong. Hang Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Guodong, Yicheng Ma, Hang Dong, et al.. (2025). Association of serum 25-hydroxyvitamin D with the risk of depression in individuals with prediabetes and diabetes: A prospective cohort study. The journal of nutrition health & aging. 29(6). 100556–100556.
2.
Dong, Hang, et al.. (2024). Activated platelet-derived exosomal LRG1 promotes multiple myeloma cell growth. Oncogenesis. 13(1). 2 indexed citations
3.
Dong, Hang, Jian Li, Xueyuan Huang, Haiting Liu, & Rong Gui. (2023). Platelet-membrane camouflaged cerium nanoparticle-embedded gelatin methacryloyl hydrogel for accelerated diabetic wound healing. International Journal of Biological Macromolecules. 251. 126393–126393. 13 indexed citations
4.
Dong, Hang, et al.. (2023). Doxorubicin-Loaded Platelet Decoys for Enhanced Chemoimmunotherapy Against Triple-Negative Breast Cancer in Mice Model. International Journal of Nanomedicine. Volume 18. 3577–3593. 12 indexed citations
5.
Zhao, Qiangqiang, Xiaoying Sun, Bin Wu, et al.. (2021). Construction of homologous cancer cell membrane camouflage in a nano-drug delivery system for the treatment of lymphoma. Journal of Nanobiotechnology. 19(1). 8–8. 54 indexed citations
6.
Shang, Yinghui, Qinghai Wang, Jian Li, et al.. (2021). Zirconia Nanoparticles Induce HeLa Cell Death Through Mitochondrial Apoptosis and Autophagy Pathways Mediated by ROS. Frontiers in Chemistry. 9. 522708–522708. 19 indexed citations
7.
Zhao, Qiangqiang, Bin Wu, Yinghui Shang, et al.. (2020). Construction of biomimetic silver nanoparticles in the treatment of lymphoma. Materials Science and Engineering C. 119. 111648–111648. 13 indexed citations
8.
Zhao, Qiangqiang, Jian Li, Bin Wu, et al.. (2020). A Nano-Traditional Chinese Medicine Against Lymphoma That Regulates the Level of Reactive Oxygen Species. Frontiers in Chemistry. 8. 565–565. 11 indexed citations
9.
Shang, Yinghui, Qinghai Wang, Jian Li, et al.. (2020). Platelet-Membrane-Camouflaged Zirconia Nanoparticles Inhibit the Invasion and Metastasis of Hela Cells. Frontiers in Chemistry. 8. 377–377. 17 indexed citations
10.
Zhao, Qiangqiang, Bin Wu, Yinghui Shang, et al.. (2020). Development of a nano-drug delivery system based on mesoporous silica and its anti-lymphoma activity. Applied Nanoscience. 10(9). 3431–3442. 7 indexed citations
11.
Zhao, Qiangqiang, Jian Li, Bin Wu, et al.. (2020). Smart Biomimetic Nanocomposites Mediate Mitochondrial Outcome through Aerobic Glycolysis Reprogramming: A Promising Treatment for Lymphoma. ACS Applied Materials & Interfaces. 12(20). 22687–22701. 37 indexed citations
12.
Gui, Rong, Xueyuan Huang, Yunfeng Fu, et al.. (2019). Establishment of the Normal Reference Range of Thrombelas-togram among the Healthy Population and Pregnants in China. Iranian Journal of Public Health. 9 indexed citations
13.
Yuan, Xiaoli, et al.. (2017). Does cervical lymph node recurrence after oesophagectomy or definitive chemoradiotherapy for thoracic oesophageal squamous cell carcinoma benefit from salvage treatment?. Interactive Cardiovascular and Thoracic Surgery. 24(5). 792–795. 6 indexed citations
14.
Dong, Hang, et al.. (2017). To compare the efficacy between fixation with tightrope and screw in the treatment of syndesmotic injuries: A meta-analysis. Foot and Ankle Surgery. 25(1). 63–70. 22 indexed citations
15.
Ge, Jun, Hongfeng Gou, Ye Chen, et al.. (2013). Clinical Characteristics of Patients With Solitary Pulmonary Mass After Radical Treatment for Primary Cancers: Pulmonary Metastasis or Second Primary Lung Cancer?. Cancer Investigation. 31(6). 397–403. 8 indexed citations
16.
17.
Pan, Si-Yuan, Hang Dong, Haiyan Fang, et al.. (2008). Schisandrin B from Schisandra chinensis reduces hepatic lipid contents in hypercholesterolaemic mice. Journal of Pharmacy and Pharmacology. 60(3). 399–403. 46 indexed citations
18.
Dong, Hang, Jianjie Wang, Akira Hirose, et al.. (2007). The phosphatidylethanolamine N-methyltransferase gene V175M single nucleotide polymorphism confers the susceptibility to NASH in Japanese population. Journal of Hepatology. 46(5). 915–920. 94 indexed citations
19.
Pan, Si-Yuan, Hang Dong, Zhi‐Ling Yu, et al.. (2007). Bicyclol, a synthetic dibenzocyclooctadiene derivative, decreases hepatic lipids but increases serum triglyceride level in normal and hypercholesterolaemic mice. Journal of Pharmacy and Pharmacology. 59(12). 1657–1662. 14 indexed citations
20.
Pan, Si-Yuan, Rong Yang, Hang Dong, Zhi‐Ling Yu, & Kam‐Ming Ko. (2006). Bifendate treatment attenuates hepatic steatosis in cholesterol/bile salt- and high-fat diet-induced hypercholesterolemia in mice. European Journal of Pharmacology. 552(1-3). 170–175. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhen Liang Breakdown of academic impact, for papers by Xiaojun Ji Breakdown of academic impact, for papers by Melissa Skibba Breakdown of academic impact, for papers by Shengju Yang Breakdown of academic impact, for papers by Jia Gu Breakdown of academic impact, for papers by Jiaxuan Qiu Breakdown of academic impact, for papers by Yue Pan Breakdown of academic impact, for papers by Ruiyan Pan Breakdown of academic impact, for papers by Maolei Xu
Rankless by CCL
2026